All comers are eligible in second line urothelial cancer with Atezolizumab

All comers are eligible in second line urothelial cancer with Atezolizumab

AnnualMeeting2016

3 years
467 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Dr. Petros Grivas, MD of Cleveland Clinic mentions that all comers are eligible in second line Atezolizumab
Up Next Autoplay